PHILADELPHIA, May 8, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced today that it has substantially reduced implementation timelines for its flagship eCOA solution, TrialMax®. By leveraging process and technology enhancements, Signant's operational teams can reduce the time it takes to go live with electronic patient-reported outcomes solutions by thirty percent or more.

费城，2024年5月8日/PRNewswire/--现代临床试验证据生成的领导者Signant Health今天宣布，它大大缩短了其旗舰eCOA解决方案TrialMax®的实施时间表。通过利用流程和技术改进，Signant的运营团队可以将使用电子患者报告结果解决方案所需的时间减少30%或更多。

.

.

Sponsors and Contract Research Organizations (CROs) have relied on Signant's eCOA solution for over 20 years. The solution is known for its flexibility, reliability, scientific support, global logistics support, and ability to scale to any size trial, anywhere in the world. Traditionally, the time to bring the system live for patients and sites was commensurate with the operational complexity and trial design.

赞助商和合同研究组织（CRO）依赖Signant的eCOA解决方案已有20多年的历史。该解决方案以其灵活性、可靠性、科学支持、全球后勤支持以及在世界任何地方进行任何规模试验的能力而闻名。传统上，为患者和现场提供系统的时间与操作复杂性和试验设计相称。

.

.

According to the company, customers can now benefit from this highly customizable eCOA solution along with Signant's leading levels of science, scale, and service – delivered under much faster timelines.

据该公司称，客户现在可以从这种高度可定制的eCOA解决方案以及Signant领先的科学、规模和服务水平中受益，这些都是在更快的时间内提供的。

'We are excited to offer customers the best of both worlds,' said Sanjiv Waghmare, Signant's chief product officer. 'They can get the fully featured, market-leading eCOA solution they already use and love, at a much faster pace. We believe this is especially meaningful as trial designs continue to increase in complexity.

Signant首席产品官桑吉夫·瓦格马尔（Sanjiv Waghmare）说，我们很高兴能为客户提供两全其美的服务他们可以以更快的速度获得他们已经使用和喜爱的功能齐全、市场领先的eCOA解决方案。我们认为，随着试验设计的复杂性不断增加，这一点尤其有意义。

We want to ensure our customers hit their FPFV dates and start collecting high quality data without worrying about if their eCOA solution will be available.'    .

我们希望确保我们的客户达到他们的FPFV日期，并开始收集高质量的数据，而不必担心他们的eCOA解决方案是否可用。”。

According to Waghmare, Signant's engineering and operational teams identified areas where process enhancements and automation could dramatically reduce common implementation steps regardless of trial complexity. These steps cover all aspects of a typical eCOA timeline including study build, testing, translations, scale management, and validation..

根据Waghmare的说法，Signant的工程和运营团队确定了流程增强和自动化可以大大减少常见实施步骤的领域，而不考虑试验的复杂性。这些步骤涵盖了典型eCOA时间表的各个方面，包括研究构建、测试、翻译、规模管理和验证。。

'This is just the beginning of our efforts to deliver complexity at speed, with outstanding quality,' continued Waghmare. 'We are also bringing additional efficiencies to our processes that will accelerate post-implementation support, including reporting, analytics, and data change management.'

瓦格马尔继续说：“这仅仅是我们努力以卓越的质量快速交付复杂性的开始。”我们还将提高流程的效率，加快实施后的支持，包括报告、分析和数据更改管理。”

Signant also offers a tenured solution for eCOA studies as part of its Signant SmartSignals® Unified Platform, which is fully integrated with EDC, RTSM, eConsent, and telemedicine. For more information about all Signant's eClinical solutions, go to www.signanthealth.com.

Signant还为eCOA研究提供终身解决方案，作为其Signant SmartSignals®统一平台的一部分，该平台与EDC、RTSM、eConsent和远程医疗完全集成。有关Signant所有电子临床解决方案的更多信息，请访问www.signanthealth.com。

About Signant Health

关于Signant Health

Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently capture, aggregate, and reveal quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 25 years, over 600 sponsors and CROs of all sizes – including all Top 20 pharma – have trusted Signant solutions for remote and site-based eCOA, EDC, eConsent, RTSM, supply chain management, and data quality analytics.

Signant Health是证据生成公司。我们专注于利用软件，深入的治疗和科学知识以及运营专业知识，以持续捕获，汇总和揭示传统，虚拟和混合试验模型中临床研究的高质量证据。25年多来，600多家赞助商和各种规模的首席风险官（包括所有排名前20位的制药公司）都拥有值得信赖的Signant解决方案，可用于远程和基于站点的eCOA、EDC、eConsent、RTSM、供应链管理和数据质量分析。

Learn more at www.signanthealth.com..

更多信息，请访问www.signanthealth.com。。

Contact:

联系人：

Heather Bilinskimedia@signanthealth.com+1 610.400.4141

希瑟Bilinskimedia@signanthealth.com+1 610 400 4141

Logo - https://mma.prnewswire.com/media/1202052/Signant_Health_Logo.jpg

标志https://mma.prnewswire.com/media/1202052/Signant_Health_Logo.jpg

SOURCE Signant Health

源签名运行状况